Changes in Oral Health and Dental Esthetic in Smokers Switching to Combustion-Free Nicotine Alternatives: Protocol for a Multicenter and Prospective Randomized Controlled Trial.

MGI Modified Gingival Index dental plaque imaging dental shade electronic cigarettes gingivitis heated tobacco products mobile phone oral health periodontitis smartphone smoking tobacco harm reduction

Journal

JMIR research protocols
ISSN: 1929-0748
Titre abrégé: JMIR Res Protoc
Pays: Canada
ID NLM: 101599504

Informations de publication

Date de publication:
23 Feb 2024
Historique:
received: 29 09 2023
accepted: 28 12 2023
revised: 27 12 2023
medline: 23 2 2024
pubmed: 23 2 2024
entrez: 23 2 2024
Statut: epublish

Résumé

Although the detrimental effects of conventional combustible cigarettes on oral health and dental esthetics are well known, there is limited information about the long-term impact of combustion-free nicotine alternatives (C-F NA) such as e-cigarettes or heated tobacco products. This multicenter, prospective, 3-parallel-arm randomized controlled trial will investigate whether switching from combustible cigarettes to C-F NA will lead to measurable improvements in oral health parameters and dental esthetics over 18 months in adult smokers with limited gum disease. Regular smokers not intending to quit and without clinical signs of periodontitis will be randomly assigned (1:4 ratio) to either standard of care with brief cessation advice (control group; arm A) or C-F NA use (intervention group; arm B). The study will also include a reference group of never smokers (reference group; arm C). The primary end point is the change in the Modified Gingival Index (MGI) score from baseline between the control arm (arm A) and the intervention arm (arm B) at the 18-month follow-up. In addition, the study will analyze the within- and between-group (arms A, B, and C) changes in MGI assessment, plaque imaging, dental shade quantitation, tooth stain scores, and oral health-related quality of life questionnaires measured at each study time point. All participants will attend a total of 7 clinic visits: screening, enrollment, and randomization (visit 0); baseline visit-day 14 (visit 1); day 90 (visit 2); day 180 (visit 3); day 360 (visit 4); and day 540 (visit 5). This multicenter study will be conducted in 4 dental clinics in 4 countries. The statistical analysis will involve descriptive statistics for continuous and categorical data. Primary end points will undergo tests for normality and, based on distribution, either a 2-sided t test or Mann-Whitney U test. Linear mixed model with random factors center and study arms by center will also be applied. Secondary end points, including MGI assessment and quality of life, will be subjected to similar tests and comparisons. Only if one value of the parameter MGI is missing after day 1, the last available observation will be carried forward. The analysis will be performed on the substituted data. Secondary parameters will not have missing value replacement. Participant recruitment began in October 2021, and enrollment was completed in June 2023. Results will be reported in 2025. This will be the first study to provide key insights into oral health benefits or risks associated with using C-F NA in smokers who are seeking alternatives to cigarette smoking. ClinicalTrials.gov NCT04649645; https://clinicaltrials.gov/ct2/show/NCT04649645. DERR1-10.2196/53222.

Sections du résumé

BACKGROUND BACKGROUND
Although the detrimental effects of conventional combustible cigarettes on oral health and dental esthetics are well known, there is limited information about the long-term impact of combustion-free nicotine alternatives (C-F NA) such as e-cigarettes or heated tobacco products.
OBJECTIVE OBJECTIVE
This multicenter, prospective, 3-parallel-arm randomized controlled trial will investigate whether switching from combustible cigarettes to C-F NA will lead to measurable improvements in oral health parameters and dental esthetics over 18 months in adult smokers with limited gum disease.
METHODS METHODS
Regular smokers not intending to quit and without clinical signs of periodontitis will be randomly assigned (1:4 ratio) to either standard of care with brief cessation advice (control group; arm A) or C-F NA use (intervention group; arm B). The study will also include a reference group of never smokers (reference group; arm C). The primary end point is the change in the Modified Gingival Index (MGI) score from baseline between the control arm (arm A) and the intervention arm (arm B) at the 18-month follow-up. In addition, the study will analyze the within- and between-group (arms A, B, and C) changes in MGI assessment, plaque imaging, dental shade quantitation, tooth stain scores, and oral health-related quality of life questionnaires measured at each study time point. All participants will attend a total of 7 clinic visits: screening, enrollment, and randomization (visit 0); baseline visit-day 14 (visit 1); day 90 (visit 2); day 180 (visit 3); day 360 (visit 4); and day 540 (visit 5). This multicenter study will be conducted in 4 dental clinics in 4 countries. The statistical analysis will involve descriptive statistics for continuous and categorical data. Primary end points will undergo tests for normality and, based on distribution, either a 2-sided t test or Mann-Whitney U test. Linear mixed model with random factors center and study arms by center will also be applied. Secondary end points, including MGI assessment and quality of life, will be subjected to similar tests and comparisons. Only if one value of the parameter MGI is missing after day 1, the last available observation will be carried forward. The analysis will be performed on the substituted data. Secondary parameters will not have missing value replacement.
RESULTS RESULTS
Participant recruitment began in October 2021, and enrollment was completed in June 2023. Results will be reported in 2025.
CONCLUSIONS CONCLUSIONS
This will be the first study to provide key insights into oral health benefits or risks associated with using C-F NA in smokers who are seeking alternatives to cigarette smoking.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT04649645; https://clinicaltrials.gov/ct2/show/NCT04649645.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) UNASSIGNED
DERR1-10.2196/53222.

Identifiants

pubmed: 38393754
pii: v13i1e53222
doi: 10.2196/53222
doi:

Banques de données

ClinicalTrials.gov
['NCT04649645']

Types de publication

Journal Article

Langues

eng

Pagination

e53222

Informations de copyright

©Gianluca Conte, Sebastiano Antonio Pacino, Salvatore Urso, Doris Greiling, Pasquale Caponnetto, Eugenio Pedullà, Luigi Generali, Ugo Consolo, Vittorio Checchi, Stefan Gospodaru, Gheorghe Bordeniuc, Valeriu Fala, Jan Kowalski, Maciej Nowak, Renata Górska, Amaliya Amaliya, Iain Chapple, Michael Milward, Robert Maclure, Gianna Maria Nardi, Riccardo Polosa. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 23.02.2024.

Auteurs

Gianluca Conte (G)

Addendo srl, Dental Clinic, Catania, Italy.

Sebastiano Antonio Pacino (SA)

Addendo srl, Dental Clinic, Catania, Italy.
ECLAT Srl, Spin-off of the University of Catania, Catania, Italy.

Salvatore Urso (S)

ECLAT Srl, Spin-off of the University of Catania, Catania, Italy.
Department of Biological, Geological and Environmental Sciences, University of Catania, Catania, Italy.

Doris Greiling (D)

Forschungsdock CRO GmbH, Schenefeld, Germany.

Pasquale Caponnetto (P)

Center of Excellence for the Acceleration of HArm Reduction, University of Catania, Catania, Italy.
Department of Educational Sciences, Section of Psychology, University of Catania, Catania, Italy.

Eugenio Pedullà (E)

Center of Excellence for the Acceleration of HArm Reduction, University of Catania, Catania, Italy.
Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.

Luigi Generali (L)

Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, Modena, Italy.

Ugo Consolo (U)

Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, Modena, Italy.

Vittorio Checchi (V)

Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, Modena, Italy.

Stefan Gospodaru (S)

Faladental, Chișinău, Republic of Moldova.

Gheorghe Bordeniuc (G)

Faladental, Chișinău, Republic of Moldova.

Valeriu Fala (V)

Faladental, Chișinău, Republic of Moldova.

Jan Kowalski (J)

Department of Periodontology, Medical University of Warsaw, Warsaw, Poland.

Maciej Nowak (M)

Department of Periodontology, Medical University of Warsaw, Warsaw, Poland.

Renata Górska (R)

Department of Periodontology, Medical University of Warsaw, Warsaw, Poland.

Amaliya Amaliya (A)

Department of Periodontology, Faculty of Dentistry, Universitas Padjadjaran, West Java, Indonesia.

Iain Chapple (I)

Periodontal Research Group, The University of Birmingham & Birmingham Community Healthcare Trust, Birmingham, United Kingdom.

Michael Milward (M)

Periodontal Research Group, The University of Birmingham & Birmingham Community Healthcare Trust, Birmingham, United Kingdom.

Robert Maclure (R)

R Maclure Clinical Research Ltd, Irby, Wirral, United Kingdom.

Gianna Maria Nardi (GM)

Department of Dental and Maxillofacial Sciences, Sapienza University, Rome, Italy.

Riccardo Polosa (R)

Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Classifications MeSH